173 related articles for article (PubMed ID: 1310955)
1. The severity of herpes simplex viral keratitis in mice does not reflect the severity of disease in humans.
Rinne JR; Abghari SZ; Stulting RD
Invest Ophthalmol Vis Sci; 1992 Feb; 33(2):268-72. PubMed ID: 1310955
[TBL] [Abstract][Full Text] [Related]
2. Herpes simplex virus stromal keratitis is not titer-dependent and does not correlate with neurovirulence.
Grau DR; Visalli RJ; Brandt CR
Invest Ophthalmol Vis Sci; 1989 Dec; 30(12):2474-80. PubMed ID: 2556353
[TBL] [Abstract][Full Text] [Related]
3. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
Ritchie MH; Oakes JE; Lausch RN
Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
[TBL] [Abstract][Full Text] [Related]
4. Persistence of herpes simplex virus DNA in rabbit corneal cells.
Cantin E; Chen J; Willey DE; Taylor JL; O'Brien WJ
Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2470-5. PubMed ID: 1321797
[TBL] [Abstract][Full Text] [Related]
5. Immunobiology of Langerhans cells on the ocular surface. II. Role of central corneal Langerhans cells in stromal keratitis following experimental HSV-1 infection in mice.
McLeish W; Rubsamen P; Atherton SS; Streilein JW
Reg Immunol; 1989; 2(4):236-43. PubMed ID: 2561960
[TBL] [Abstract][Full Text] [Related]
6. Patterns of herpes simplex keratitis in inbred mice.
Stulting RD; Kindle JC; Nahmias AJ
Invest Ophthalmol Vis Sci; 1985 Oct; 26(10):1360-7. PubMed ID: 4044164
[TBL] [Abstract][Full Text] [Related]
7. Herpetic keratitis in inbred mice.
Metcalf JF; Michaelis BA
Invest Ophthalmol Vis Sci; 1984 Oct; 25(10):1222-5. PubMed ID: 6480298
[TBL] [Abstract][Full Text] [Related]
8. Treatment with meliacine, a plant derived antiviral, prevents the development of herpetic stromal keratitis in mice.
Alché LE; Berra A; Veloso MJ; Coto CE
J Med Virol; 2000 Aug; 61(4):474-80. PubMed ID: 10897066
[TBL] [Abstract][Full Text] [Related]
9. The effect of flurbiprofen on herpes simplex virus type 1 stromal keratitis in mice.
Hendricks RL; Barfknecht CF; Schoenwald RD; Epstein RJ; Sugar J
Invest Ophthalmol Vis Sci; 1990 Aug; 31(8):1503-11. PubMed ID: 2167299
[TBL] [Abstract][Full Text] [Related]
10. Contribution of virus and immune factors to herpes simplex virus type I-induced corneal pathology.
Hendricks RL; Tumpey TM
Invest Ophthalmol Vis Sci; 1990 Oct; 31(10):1929-39. PubMed ID: 2170289
[TBL] [Abstract][Full Text] [Related]
11. Effect of topical cyclosporin A on herpetic stromal keratitis in a mouse model.
Yoon KC; Heo H; Kang IS; Lee MC; Kim KK; Park SH; Cho KO
Cornea; 2008 May; 27(4):454-60. PubMed ID: 18434850
[TBL] [Abstract][Full Text] [Related]
12. Spread of HSV and establishment of latency after corneal infection in inbred mice.
Abghari SZ; Stulting RD; Nigida SM; Downer DN; Nahmias AJ
Invest Ophthalmol Vis Sci; 1986 Jan; 27(1):77-82. PubMed ID: 3000975
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus entry receptor nectin-1 is widely expressed in the murine eye.
Valyi-Nagy T; Sheth V; Clement C; Tiwari V; Scanlan P; Kavouras JH; Leach L; Guzman-Hartman G; Dermody TS; Shukla D
Curr Eye Res; 2004; 29(4-5):303-9. PubMed ID: 15590476
[TBL] [Abstract][Full Text] [Related]
14. Incidence and severity of herpetic stromal keratitis: impaired by the depletion of lymph node macrophages.
Bauer D; Mrzyk S; Van Rooijen N; Steuhl KP; Heiligenhaus A
Exp Eye Res; 2001 Mar; 72(3):261-9. PubMed ID: 11180975
[TBL] [Abstract][Full Text] [Related]
15. Activation of NK cells in mice following corneal infection with herpes simplex virus type-1.
Brandt CR; Salkowski CA
Invest Ophthalmol Vis Sci; 1992 Jan; 33(1):113-20. PubMed ID: 1370438
[TBL] [Abstract][Full Text] [Related]
16. Critical role of corneal Langerhans cells in the CD4- but not CD8-mediated immunopathology in herpes simplex virus-1-infected mouse corneas.
Hendricks RL; Janowicz M; Tumpey TM
J Immunol; 1992 Apr; 148(8):2522-9. PubMed ID: 1313845
[TBL] [Abstract][Full Text] [Related]
17. The effect of cellular immune tolerance to HSV-1 antigens on the immunopathology of HSV-1 keratitis.
Hendricks RL; Epstein RJ; Tumpey T
Invest Ophthalmol Vis Sci; 1989 Jan; 30(1):105-15. PubMed ID: 2536358
[TBL] [Abstract][Full Text] [Related]
18. Effect of Fas and Fas ligand deficiency in resistance of C57BL/6 mice to HSV-1 keratitis and chorioretinitis.
Nguyen QD; Uy HS; Merchant A; Medina CA; Baltatzis S; Zhao T; Zhao ZS; Cantor H; Foster CS
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2505-9. PubMed ID: 11581190
[TBL] [Abstract][Full Text] [Related]
19. Glycoprotein C of herpes simplex virus type 1 is required to cause keratitis at low infectious doses in intact rabbit corneas.
Drolet BS; Mott KR; Lippa AM; Wechsler SL; Perng GC
Curr Eye Res; 2004; 29(2-3):181-9. PubMed ID: 15512965
[TBL] [Abstract][Full Text] [Related]
20. Prevention of herpes keratitis by monoclonal antibodies specific for discontinuous and continuous epitopes on glycoprotein D.
Lousch RN; Staats H; Oakes JE; Cohen GH; Eisenberg RJ
Invest Ophthalmol Vis Sci; 1991 Sep; 32(10):2735-40. PubMed ID: 1716618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
